Navigation Links
Breast cancer treatment to be determined by gene test

Women newly diagnosed with breast cancer, may opt for mastectomy over breast-conserving lumpectomy if they test positive for a breast cancer gene mutation, researchers said California on Monday.

About 5% to 10% of all breast cancers are caused by an inherited genetic susceptibility. The majority of these cancers are linked to mutations or alterations in two genes, BRCA1 and BRCA2. It is estimated that mutation carriers have a 55% to 85% risk of breast cancer risk by age 70, while carriers with breast cancer have about a 35% 10-year risk of developing cancer in the opposite breast.

To determine the psychological impact of BRACA test results on women with breast cancer, Dr. Claudine Isaacs and colleagues at Georgetown University in Washington, D.C., offered rapid genetic testing and counseling to 175 newly diagnosed breast cancer patients who were candidates for either lumpectomy or mastectomy treatment.

The genetic testing and counseling changed the view of the patients and made them take up the surgery eagerly. This way, women were more willing to take up the painful decision of undergoing a mastectomy more cheerfully.
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast Feeding prevents obesity later on in life
3. Breast milk is essential
4. Breast Cancer Surgery Causes Psychological problems
5. Breast cancer evidence
6. Letrozole Beats Tamoxifen in Breast Cancer Therapy
7. Breast screening among diabetic women
8. Breast feeding can alter hormones
9. Diet, Sunlight connected to Breast Cancer Risk
10. Additional Radiotheraphy for Breast Cancer
11. Early Warning System For Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... 2017 , ... The Margarian Law Firm has filed a class action ... for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ... alleges Canada Dry Ginger Ale claims on its bottle that it is made from ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... bone marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense ... chance of reoccurrence and relapse. With such a challenging diagnosis that requires ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based biotechnology company ... the completion of a $12.7 million Series A financing round. ... as the participation of existing investors. ... of New Ventures III and our current investors, and view ... of our platform technology to transform the course of PD ...
Breaking Medicine Technology: